Sonia Benhamida, PhD, serves as Director at BlackRock since August 2023 and has been Principal at Kreos Capital since May 2021. Previously, Sonia held the position of Senior Vice President at DNB from October 2017 to February 2021 and Vice President of Business Development R&D at Ipsen from July 2010 to September 2017, focusing on early-stage oncology, neurology, and endocrinology opportunities. Additional roles include Business Development Senior Director for Oncology at Ipsen and Director of Transaction Modelling at Rothschild. Educational credentials include a Master's Degree in Business Administration from HEC Paris, a PhD in Molecular and Cellular Biology from Université Paris Cité, and a Graduate degree in Biotechnology from AgroParisTech. Early research involved in vitro and in vivo studies for gene therapy concerning X-linked adrenoleukodystrophy.
This person is not in any teams
This person is not in any offices